News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Orchard Therapeutics Enters Agreement with Beneluxa Consortium to Facilitate Reimbursed Access to Libmeldy
Friday, January 26, 2024Orchard Therapeutics a prominent global gene therapy company has recently announced a new agreement with the Beneluxa Initiative on Pharmaceutical Policy This agreement aims to facilitate reimbursed access to Libmeldy
Elegen and GSK Have Entered Into a Collaborative Licensing Agreement to Further Advance the Development of Elegen's Technology for Cell-free DNA Production
Thursday, January 25, 2024Elegen a leader in DNA manufacturing innovation has announced a collaboration and licensing agreement with GSK The partnership aims to utilize Elegens proprietary technology for the production of cellfree DNA
Biomunex Pharmaceuticals commences Phase 1 Clinical Trial for its pioneering Bispecific Antibody designed for Cancer Treatment
Thursday, January 25, 2024Biomunex Pharmaceuticals a prominent French biopharmaceutical company specializing in advanced immunotherapy development through bi and multispecific antibodies from its BiXAb platform has announced the initiation of a Phase clinical trial
Vivtex and Astellas Pharma Announce a Collaborative Research Partnership
Wednesday, January 24, 2024Vivtex Corporation a biotech company focused on advancing oral biologic therapies for major diseases has recently initiated a research collaboration with Astellas Pharma Inc a global pharmaceutical company The collaboration aims to assess Vivtexs pro...
Oncodesign Services Acquires ZoBio, Strengthening Expertise in Small Molecule Drug Discovery
Wednesday, January 24, 2024Oncodesign Services a leading Contract Research Organization specializing in drug discovery and preclinical services is expanding globally through the acquisition of ZoBio a Dutch Contract Research Organization
GenEdit, Genentech Collaborate on Nanoparticles for Autoimmune Genetic Medicines
Wednesday, January 24, 2024GenEdit Inc a developer of genetic medicines using its NanoGalaxy platform for precise tissue delivery has recently entered into a multiyear collaboration and license agreement with Genentech a member of the Roche Group
The European Commission Has Granted Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis With Polyangiitis
Tuesday, January 23, 2024NS Pharma Inc a subsidiary of Nippon Shinyaku Co Ltd has received orphan drug designation from the European Commission for NS a drug under development to treat the rare disease eosinophilic granulomatosis with polyangiitis
Kyverna Therapeutics Has Been Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Saturday, January 20, 2024Kyverna Therapeutics Inc has recently been granted fast track designation by the US Food and Drug Administration for its autologous CD chimeric antigen receptor Tcell product candidate
STEMCELL Technologies Finalizes Acquisition of Propagenix Inc
Saturday, January 20, 2024STEMCELL Technologies a prominent biotechnology company based in Canada is pleased to announce its recent acquisition of Propagenix Inc a biotechnology firm located in Maryland Propagenix is known for its focus on developing
Synendos Therapeutics AG Secures EMA Approval for Clinical Trials of Pioneering Endocannabinoid System Modulator, SYT-510
Friday, January 19, 2024Synendos Therapeutics AG a leader in innovative Endocannabinoid System treatments has received approval from the European Medicines Agency to initiate the Phase clinical trial for its lead compound
